Want to see IN:GPTHEALTH full AI Analyst Report?
GPTHEALTH Stock Chart & Stats
₹147.85
-₹0.33(-0.18%)
At close: 4:00 PM EST
₹147.85
-₹0.33(-0.18%)
Day’s Range― - ―
52-Week Range₹114.00 - ₹175.00
Previous CloseN/A
Volume58.95K
Average Volume (3M)11.05K
Market Cap
₹13.06B
Enterprise Value₹9.87K
Total Cash (Recent Filing)₹364.31M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)27.4
Beta0.83
Next Earnings
Nov 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.57%
Share Statistics
EPS (TTM)5.81
Shares Outstanding82,054,825
10 Day Avg. Volume8,914
30 Day Avg. Volume11,051
Financial Highlights & Ratios
PEG Ratio-1.46
Price to Book (P/B)3.50
Price to Sales (P/S)2.00
P/FCF Ratio23.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.7
Revenue Forecast (FY)₹5.58B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthConsistent revenue expansion indicates sustained demand and growing operating scale. The FY2026 re-acceleration strengthens the medium-term growth profile, although future returns will depend on converting sales growth into stable profitability.
Improved Balance SheetThe materially lower leverage supports financial resilience and gives the company greater flexibility to fund operations and expansion. Expanded equity and approximately 15.7% ROE further support the quality of the capital structure.
Solid Operating Cash FlowOperating cash flow slightly exceeding reported earnings suggests that FY2026 profits were broadly supported by cash generation rather than accounting accruals. This improves earnings quality and helps fund the business internally despite uneven free cash flow.
Bears Say
Margin CompressionFalling margins and declining net income despite sales growth indicate rising costs, investment requirements, or operating inefficiency. If persistent, this would limit the company’s ability to translate market expansion into durable earnings growth.
Volatile Free Cash FlowUneven free-cash-flow conversion creates uncertainty around the cash available for reinvestment, debt reduction, or shareholder returns. The pattern may reflect elevated capital spending or working-capital needs that could remain a structural constraint.
Debt Reversal And Lower ROEThe FY2026 increase in debt reduces some of the earlier deleveraging progress and may raise financial risk if profitability remains under pressure. Lower ROE also suggests that the company is generating less return from its expanded equity base.
GPT Healthcare Limited News
GPTHEALTH FAQ
What was GPT Healthcare Limited’s price range in the past 12 months?
GPT Healthcare Limited lowest stock price was ₹114.00 and its highest was ₹175.00 in the past 12 months.
What is GPT Healthcare Limited’s market cap?
GPT Healthcare Limited’s market cap is ₹13.06B.
When is GPT Healthcare Limited’s upcoming earnings report date?
GPT Healthcare Limited’s upcoming earnings report date is Nov 14, 2026 which is in 60 days.
How were GPT Healthcare Limited’s earnings last quarter?
GPT Healthcare Limited released its earnings results on Aug 03, 2026. The company reported ₹1.552 earnings per share for the quarter.
Is GPT Healthcare Limited overvalued?
According to Wall Street analysts GPT Healthcare Limited’s price is currently Overvalued.
Does GPT Healthcare Limited pay dividends?
GPT Healthcare Limited pays a Semiannually dividend of ₹1.5 which represents an annual dividend yield of 1.57%. See more information on GPT Healthcare Limited dividends here
What is GPT Healthcare Limited’s EPS estimate?
GPT Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GPT Healthcare Limited have?
GPT Healthcare Limited has 82,054,825 shares outstanding.
What happened to GPT Healthcare Limited’s price movement after its last earnings report?
GPT Healthcare Limited reported an EPS of ₹1.552 in its last earnings report. Following the earnings report the stock price went down -3.903%.
Which hedge fund is a major shareholder of GPT Healthcare Limited?
Currently, no hedge funds are holding shares in IN:GPTHEALTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GPT Healthcare Limited
GPT Healthcare Limited runs a network of multispecialty hospitals across India under the ILS Hospitals brand. The company provides an extensive array of medical services, encompassing internal medicine, diabetology, and specialized nephrology procedures like renal transplants. Its offerings also include various laparoscopic and general surgeries, gynecology and obstetrics, critical care, gastroenterology, orthopedics with joint replacement, interventional cardiology, neurosciences, pediatrics, diagnostic facilities, and neonatology. Furthermore, the company manages its own pharmacies. Established in 1989, GPT Healthcare Limited is headquartered in Kolkata, India, and operates as a subsidiary of GPT Sons Pvt. Ltd.
Technical Analysis
Artemis Medicare Services Ltd.
―
Indraprastha Medical Corporation Limited
―
Shalby Ltd.
―
Suraksha Diagnostic Ltd.
―
Kovai Medical Center & Hospital Ltd.
―